By
Private equity firm Kedaara Capital has emerged as the leading contender to buy a majority stake in Tynor Orthotics, a Punjab-based company that makes fracture supports, braces and other orthopaedic aids, Mint reported, citing people familiar with the matter.
The proposed deal could value Tynor Orthotics at around ₹3,500–4,000 crore ($40m-$48m). As part of the transaction, existing investor Lighthouse Funds and the company’s promoters are expected to sell nearly 60% of their combined stake, the report said.
Tynor had restarted the stake sale process in mid-2025 after previous talks with Singapore-based investment firm Temasek did not move forward, according to an earlier Mint report. Temasek had earlier explored buying a significant minority stake in the company in 2024, but discussions were put on hold. After that, Tynor appointed O3 Capital to manage the renewed sale process, the report added.
The potential acquisition highlights the growing investor interest in consumer-focused healthcare companies in India. Rising health insurance coverage, better affordability of medical products and a growing patient base have made medical devices an attractive segment for private equity investors.
-1.png "Gaza Fund (1)-1")
